StockVS

M Evo Global Acquisition Corp II (MEVO) 股票分析

金融服务

M Evo Global Acquisition Corp II

$9.92

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

M Evo Global Acquisition Corp II operates as a special purpose acquisition company (SPAC) focused on executing business combinations through mergers, amalgamations, share exchanges, asset acquisitions, share purchases, or reorganizations with one or more private businesses. The company functions within the Financial Services sector, specifically categorized under the industry of Shell Companies, which implies it currently exists primarily as a vehicle awaiting a target transaction rather than operating a standalone commercial business model. As of the latest available data, the company holds a market capitalization of $476.08 million, while its annual revenue is not applicable as a going concern metric due to its pre-business combination status, and it employs an indeterminate number of staff listed as N/A. These valuation and operational metrics indicate that the entity represents a speculative financial instrument with a market value driven by investor expectations of a future merger rather than by current operational cash flows or established revenue streams typical of mature financial service providers.

财务健康

The company reports a net income of $-119,861 for the trailing twelve months, while both revenue and EBITDA figures are not applicable, revealing a cost structure where traditional operating expenses and income statements have not yet been generated through commercial activities. Free cash flow is not applicable, indicating that the company does not currently generate operational cash flows to fund capital expenditures or working capital needs, relying instead on trust account proceeds or financing. All three key margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which reflects the absence of revenue generation and standard operating leverage associated with a shell company structure prior to a merger. The balance sheet shows a debt obligation of $10 against a cash balance that is not applicable, resulting in a debt-to-equity ratio of 0.06, suggesting a leveraged position relative to equity but one that is minimal in absolute terms for a SPAC vehicle. The current ratio stands at 0.11, which indicates significant short-term liquidity constraints typical of SPACs that must manage trust account redemptions and transaction costs before a deal closes. Return on equity and return on assets are both not applicable, as these return metrics cannot be meaningfully calculated without substantial shareholder equity or asset bases derived from ongoing business operations.

估值评估

The trailing P/E ratio and forward P/E ratio are both not applicable, implying that standard valuation multiples based on earnings are unavailable for a company that has not yet realized profitable operations or established a consistent earnings trajectory. The price-to-book ratio is recorded at -3283.33, a figure that indicates an extreme deviation from book value often seen in SPACs where the market price can diverge significantly from the net asset value of the trust or shell structure. Price-to-sales and EV/EBITDA metrics are also not applicable, as the lack of sales and earnings prevents the use of these alternative valuation methods to assess the company's intrinsic value relative to its revenue or cash generation potential. The stock has traded between a 52-week high of $9.95 and a 52-week low of $9.83, meaning the current market price sits within a very narrow range near the upper bound of its recent trading history. The beta value is not applicable, which implies that the stock's price volatility cannot be statistically correlated to broader market movements due to the lack of historical trading data or the unique structural risks inherent to shell companies.

Growth & Income

Revenue growth and earnings growth rates are both not applicable, reflecting the fact that the company has not yet generated the revenue base required to calculate year-over-year growth percentages or compare earnings expansion against top-line performance. The company does not pay dividends, as indicated by a not applicable dividend yield and payout ratio, meaning it retains all available capital for potential merger transactions rather than distributing income to shareholders. Consequently, the company reinvests its resources into pursuing a business combination to create value for shareholders through equity appreciation rather than through periodic dividend payments. The overall growth and income profile is characterized by a complete absence of historical financial performance data, with value creation entirely dependent on the successful execution of a future merger agreement and the subsequent integration of a target business.

同行比较

M Evo Global Acquisition Corp II (MEVO) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
M Evo Global Acquisition Corp II MEVO $479.47M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。M Evo Global Acquisition Corp II的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于M Evo Global Acquisition Corp II

M Evo Global Acquisition Corp II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is headquartered in Farmers Branch, Texas.

公司简介以英文显示。

关键指标

市值
$479.47M
市盈率
N/A
52周最高
$9.95
52周最低
$9.83
平均成交量
27.38K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States